<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        40-290-20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2020
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        CLASGEN
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CICLOSPORIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Ophthalmic use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Eye drops
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        0
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Single Dose Container
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        117.50
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Huons Co., Ltd." />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Huons Co., Ltd.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 530]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Salehiya Trading Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Amman Pharmaceutical Industries (API)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        S01XA18
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- Pharmacotherapeutic group: Immunosuppressants.</p><p>- Therapeutic indications: ClasGen is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>a. Do not administer ClasGen Eye Drops to</strong></p><p>&nbsp;- Patients who have active ophthalmic infection</p><p>- Patients have hypersensitiveness for this drug or might have hypersensitiveness for this drug</p><p>&nbsp;-If contact lenses are worn, they should be removed prior to the administration of the solution. Lenses may be reinserted 15 minutes following administration of this drug</p><p><strong>b. Take special care with ClasGen Eye Drops </strong></p><p>- This drug should be used for ophthalmic disease.</p><p>- Do not touch tip of container to eyes as this may injure the eyes.</p><p><strong>c. Using with other medicines, herbal or dietary supplements </strong></p><p>- This drug can be used concomitantly with artificial tears, allowing a 15 minute interval between products.</p><p><strong>d. Using ClasGen Eye Drops with food and drink </strong></p><p>-N/A</p><p><strong>e. Pregnancy and breast-feeding </strong></p><p>Pregnancy</p><p>Risk Summary:</p><p>Clinical administration of cycloSPORINE ophthalmic Eye Drop 0.05% is not detected systemically following topical ocular administration and maternal use is not expected to result in fetal exposure to the drug. Oral administration of cycloSPORINE to pregnant rats or rabbits did not produce teratogenicity at clinically relevant doses.</p><p>Data</p><p>&nbsp;Animal Data</p><p>&nbsp;At maternaly toxic doses (rats at 30 mg/kg/day and rabbits at 100 mg/kg/day), cycloSPORINE oral solution, USP, was teratogenic as indicated by increased pre- and postnatal mortality and reduced fetal weight together with related skeletal retardations. These doses are 5,000 and 32,000 times greater (normalized to body surface area), respectively, than the daily human dose of one drop (approximately 28 mcL) of 0.05% cycloSPORINE Eye Drops twice daily into each eye of a 60 kg person (0.001 mg/kg/day), assuming that the entire dose is absorbed. No evidence of embryofetal toxicity was observed in rats or rabbits receiving cycloSPORINE at oral doses up to 17 mg/kg/day or 30 mg/kg/day, respectively, during organogenesis. These doses in rats and rabbits are approximately 3,000 and 10,000 times greater (normalized to body surface area), respectively, than the daily human dose.</p><p>Offspring of rats receiving a 45 mg/kg/day oral dose of cycloSPORINE from Day 15 of pregnancy until Day 21 postpartum, a maternally toxic level, exhibited an increase in postnatal mortality; this dose is 7,000 times greater than the daily human topical dose (0.001 mg/kg/day) normalized to body surface area assuming that the entire dose is absorbed. No adverse events were observed at oral doses up to 15 mg/kg/day (2,000 times greater than the daily human dose). There are no adequate and well-controlled studies of cycloSPORINE Eye Drops in pregnant women. cycloSPORINE Eye Drops should be administered to a pregnant woman only if clearly needed.</p><p>&nbsp;Lactation</p><p>Risk summary</p><p>&nbsp;cycloSPORINE is known to appear in human milk following systemic administration but &nbsp;excretion in human milk after topical treatment has not been investigated. Although blood concentrations are undetectable after topical administration of cycloSPORINE Eye Drops ophthalmic, caution should be exercised when cycloSPORINE Eye Drops is administered to a nursing woman. The developmental and health benefits of breastfeeding should be &nbsp;considered along with the mother&#39;s clinical need for cycloSPORINE Eye Drops and any potential adverse effects on the breast-fed child from cycloSPORINE.</p><p><strong>f. Driving and using machines &nbsp;</strong></p><p>- N/A</p><p><strong>g. Important information about some of the ingredients of ClasGen Eye Drops </strong></p><p>- This drug contains phosphate. As for some patients who have severe corneal damage, it was reported that there could be cornea calcification for these patients very rarely when used phosphate. (0.01%).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Instill one drop of this drug twice a day in each eye approximately 12 hours apart. This drug can be used concomitantly with artificial tears, allowing a 15 minute interval between products. Discard vial after use.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-Commonest adverse reaction: Ocular burning (17%)</p><p>-Other adverse reaction reported from 1 - 5 % patients: conjunctival hyperemia, discharge, epiphora, eye pain, foreign body sensation, pruritus, stinging and visual disturbance (Most often blurring)</p><p>- Adverse reaction from post marketing: Difficult to estimate the frequency or establish a causal relationship to drug exposure, but reported that there have been eye swelling, hypersensitivity (including rare cased of sever angioedema, face swelling, tongue swelling, pharyngeal edema, and dyspnea), superficial injury of the eye (from the vial tip touching the eye during administration), burning sensation, pruritus, and hives.</p><p>- Post marketing Surveillance in domestic market</p><p>In South Korea market, the adverse reaction has been studied with 895 patients who have ophthalmic infection for 6 years after launching the product, and the symptom incident was 7.82% without a casual relation (70 patients/895 patients, 93 cases). Among those cases, the adverse reaction, which should be considered of its casual relation, was 6.48% (58 patients/ 895 patients, 76 cases) and it was reported that there were burning sensation from applied parts (26 cases), not effectiveness (11 cases), eye dry (7 cases), ophtalmalgia (7 cases), hyperaemia conjunctivae (6 cases), dysaesthesia from eyes (5 cases), tiredness from eyes (3 cases), stimulation from eyes (3 cases), secretion from eyes (2 cases), pruritus from applied parts (2 cases), corneal erosion (1 case), sticky eyes (1 case), epiphora (1 case), edema from eyes (1 case). Severe adverse reaction was not reported, but there were some unexpected adverse reactions (2.68% - 24 patients/895patients, 27 cases) which are effectiveness (11 cases), dry eye (7 cases), tiredness from eyes (3 cases) stimulation from eyes (3 cases), corneal erosion (1 case), sticky eyes (1 case) and edema from eyes (1 case).</p><p>- Excipients: This drug contains phosphate. As for some patients who have severe corneal damage, it was reported that there could be cornea calcification for these patients very rarely when used phosphate. (0.01%).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- Store in an airtight container below 30&#39;C. Should keep the drug out the reach of the children.</p><p>- Protect from light</p><p>- Do not use ClasGen after the expiry date which is stated on the box.</p><p>- Medicines should not be disposed of via wastewater or household waste. ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the&nbsp; environment.</p><p>- Do not use if cap seal is broken.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;ClasGen Eye Drops contains: cycloSPORINE 0.5 mg/mL, Concentrated Glycerin 0.5mg/mL, Monobasic Sodium Phosphate Monohydrate q.s, Dibasic Sodium Phosphate Hydrate q.S, Polyoxyl 35 Castor oil 30 mg/mL, Ethanol 1 mg/mL, Water for injection q.s</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                ClasGen Eye Drops is colorless and transparent eye drop solution in a transparent plastic container
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Manufacturer:</strong></p><p>Huons Co., Ltd.</p><p>100, Bio valley-ro, Jecheon-si,&nbsp;</p><p>Chungcheongbuk-do, Korea</p><p>&nbsp;</p><p><strong>Marketing Authorization Holder:&nbsp;</strong></p><p>Amman pharmaceutical industries&nbsp;</p><p>king Abdullah II Industrial city state- Sahab</p><p>Amman, Jordan</p><p>&nbsp;</p><p><strong>To reports any side effect(s):</strong></p><p>&nbsp;</p><p><strong>- Jordan:</strong></p><table border="0" cellspacing="0" cellpadding="0" align="left"><tbody><tr><td style="vertical-align:top"><p>- Jordan food &amp; Drug administration:</p><p>&bull; Tel: 06-5632000</p><p>&bull; Website: www.jfda.jo</p><p>&bull; Smart application phones: Jordan fda</p><p>&bull; Or by fill the side effects on the yellow card.</p></td></tr><tr><td style="vertical-align:top"><p><strong>- Saudi Arabia:</strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>The National Pharmacovigilance Centre (NPC):</p><p>&nbsp;SFDA Call Center: 19999</p><p>&nbsp;E-mail: npc.drug@sfda.gov.sa</p><p>&nbsp;Website: https://ade.sfda.gov.sa/</p><p><strong>- UAE:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>-&nbsp; Pharmacovigilance &amp; Medical Device section</p><p>&bull; P.O. Box: 1853</p><p>&bull; Tel: 80011111</p><p>&bull; Email : pv@moh.gov.ae</p><p>&bull; Drug Department</p><p>&bull; Ministry of Health &amp; Prevention</p><p>&bull; Dubai</p></td></tr></tbody></table><p>&nbsp;</p><p><strong>- For other GHC country:</strong></p><p>Please contact the relevant competent authority.</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                02/2024
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>- مجموعة التصنيف العلاجي : مثبطات المناعة.</p><p dir="RTL">- دواعي الاستعمال العلاجية: يستخدم كلاسجين لزيادة إنتاج الدموع في المرضى الذين يفترض أن يتم تثبيطها &nbsp;بسبب التهاب العين المرتبطة التهاب القرنية والملتحمة الجاف.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>أ-&nbsp;لا تستخدم قطرة العين كلاسجين لِ:</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المرضى الذين لديهم التهاب العين النشط.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المرضى الذين يعانون من فرط الحساسية لهذا الدواء أو قد يكون لديهم فرط الحساسية.</p><p>- &nbsp;إذا كنت تستخدم العدسات اللاصقة فيجب ازالتها قبل استخدام القطرة. قد يتم إعادة ارتداء العدسات بعد 15 دقيقة من اخذ هذا الدواء</p><p><strong>ب-&nbsp;خذ الاحتياطات عند استخدام قطرة العين كلاسجين :</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هذا الدواء يستخدم لأمراض العين.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تدع رأس العبوة يلامس عينيك حيث إن هذا قد يؤذي العينين.</p><p><strong>ج-&nbsp;الاستخدام مع الأدوية الأخرى، المكملات العشبية أو الغذائية :</strong></p><p>&nbsp;&nbsp;&nbsp;&nbsp; - &nbsp;يمكن استخدام هذا الدواء بالتزامن مع الدموع الاصطناعية، مما يسمح بفاصل 15 دقيقة بين المنتجات.</p><p><strong>د-&nbsp;استخدام قطرة العين كلاسجين مع الطعام والشراب</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; غير قابل للتطبيق.</p><p><strong>ه-&nbsp;الحمل والرضاعة الطبيعية</strong></p><p><strong>الحمل </strong></p><p>ملخص المخاطر:</p><p>الدراسات السريرية لم تكشف عن تأثير للمستوى الجهازي لقطرة العين سايكلوسبورين 0.05%&nbsp; بعد الاعطاء الموضعي للعين&nbsp; ولا يتوقع ان يؤدي استخدام الأمهات لتعرض الجنين للدواء. لم ينتج عن تناول الفئران الحوامل او الارانب للسايكلوسبورين عن طريق الفم الى جدوث تشوه خلقي في الجرعات ذات أهمية سريرية.</p><p>البيانات</p><p>بيانات الحيوان</p><p>في الجرعات السامة للامهات (عند الجرذان 30مجم/كجم/يوم) وعند الارانب بمعدل 100(مجم/كجم/يوم) كان محلول السايكلوسبورين المعطي بالفم ماسخا كما هو مبين في زيادة وفيات ما قبل الولادة وبعدها, وانخفاض وزن الاجنة وتأخر التكوين الهيكلي. هذه الجرعات (بعد التعديل وفق مساحة سطح الجسم) أعلى بمعدل 5000 و 32000 ضعف، على التوالي, عن الجرعة اليومية في الانسان التي هي نقطة واحدة (حوالي 28 ميكرولتير) من 0.05% سايكلوسبورين قطرة عينية مرتين يوميا في كل عين لشخص يبلغ وزنه 60 كجم (0.001 مجم/كجم/يوم) مع الافتراض بأن الجرعة بأكملها يتم امتصاصها. لم يشاهد دليل على حدوث سمية لأجنة الجرذان او الارانب التي تلقت السايكلوسبورين عن طريق الفم اثناء مرحلة تكوين الأعضاء بجرعات وصلت الى 17مجم/كجم/يوم, على التوالي خلال تكوين الأعضاء, هذه الجرعات في الجرذان والارانب اعلى بقرابة 3000 و 10000 ضعف (بعد التعديل وفق مساحة سطح الجسم) , على التوالي, عن الجرعة اليومية الموصى بها للإنسان. عند تلقي نسل الجرذان جرعة فموية للسايكلوسبورين تبلغ 45مجم/كجم/يوم ابتداء من اليوم 15 من الحمل حتى حتى اليوم 21 بعد الولادة, وهو مستوى سام&nbsp; للام. أظهرت زيادة في وفيات ما بعد والولادة, هذه الجرعة أعلى بمعدل 7000 ضعف عن الجرعة اليومية الموضعية الموصى بها عند الانسان (0.001 مجم/كجم/يوم) بعد التعديل وفق مساحة سطح الجسم على افتراض ان الجرعة بأكملها قد تم امتصاصها.</p><p>لم تشاهد أي تأثيرات ضارة مع جرعات فموية تصل الى 15 مجم/كجم/يوم (2000 مرة اعلى من الجرعة اليومية للإنسان). لا توجد دراسات كافية ومضبوطة جيدا عن سايكلوسبورين قطرة عينية في النساء الحوامل.</p><p>يجب إعطاء سايكلوسبورين قطرة عينية للمرأة الحامل فقط اذا لزم الأمر.</p><p><strong>الرضاعة </strong></p><p>ملخص مخاطر الرضاعة</p><p>من المعروف ان السايكلوسبورين يظهر في حليب الام عقب الاستعمال الجهازي. غير انه لم تجر أبحاث على تواجده في حليب الام عقي العلاج الموضعي على الرغم من عدم وجود تركيزات قابلة للقياس في الدم عقب الاستعمال الموضعي ل سايكلوسبورين قطرة عينية, الا انه يجب توخي الحذر عند إعطاء سايكلوسبورين قطرة عينية للمرأة المرضعة.</p><p>ينبغي النظر في الفوائد التنموية والصحية للرضاعة الطبيعية جنبا الى جنب مع حاجة الام السريرية</p><p>لسايكلوسبورين قطرة عينية وأي اثار سلبية محتملة من السايكلوسبورين على الطفل الذي يرضع طبيعيا.</p><p><strong>و- القيادة واستخدام الالات: </strong></p><p>غير قابل للتطبيق</p><p><strong>ز-معلومات مهمة حول بعض مكونات قطرة العين كلاسجين</strong></p><p>-يحتوي هذا الدواء على الفوسفات. اما بالنسبة لبعض المرضى الذين لديهم أضرار حادة في القرنية, فقد افيد انه يمكن ان يكون هنالك تكلس في القرنية لهؤلاء المرضى في حالات نادرة جدا عند استخدام الفوسفات. (0.01%) &nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">ضع قطرة واحدة من هذا الدواء مرتين في اليوم في كل عين كل 12 ساعة تقريبا. يمكن استخدام هذا الدواء بالتزامن مع الدموع الصناعية, مع السماح بفترة انتظار بمقدار 15 دقيقة بين المستحضرات. تخلص من العبوة بعد الاستعمال.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>-رد فعل عكسي شائع: حرق في العين 17%</p><p>- ردود فعل عكسية سلبية أخرى تم الإبلاغ عنها في 1-5% من المرضى: احتقان الملتحمة, افرازات, شحوب, ألم في العين, الإحساس بجسم غريب, حكة, لذعة واضطرابات بصرية (غالبا ما تكون تشوش في الرؤية)</p><p>- رد فعل عكسي من مرحلة ما بعد التسويق: من الصعب تقدير التكرار او إقامة علاقة سببية مع استخدام الدواء, ولكن تم الإبلاغ حدوث تورم في العين, فرط الحساسة ( بما في ذلك حالات نادرة من الوذمة الوعائية, تورم الوجه, تورم اللسان, وذمة البلعوم, وضيق التنفس), إصابة سطحية للعين ( من طرف العبوة التي تلامس العين اثناء الاعطاء), الشعور بحرقان , حكة, وظهور بقع تشبه خلايا النحل.</p><p>- مراقبة ما بعد التسويق في السوق المحلية</p><p>في سوق كوريا الجنوبية ، تمت دراسة التفاعل العكسي مع 895 مريض مصاب بالتهاب العين لمدة 6 سنوات بعد إطلاق المنتج ، وكان حدوث الأعراض بنسبة 7.82٪ بدون علاقة سببية (70 مريضًا / 895 مريضًا ، 93 حالة). من بين تلك الحالات ، كان رد الفعل العكسي ، الذي يجب اعتباره علاقة سببية، 6.48٪ (58 مريضًا / 895 مريضًا ، 76 حالة) وتم الإبلاغ عن وجود إحساس بالحرق من الأجزاء التي يتم تطبيق الدواء عليها (26 حالة) ، وعدم الفعالية (11 حالة) ، جفاف العين (7 حالات) ، ألم العين (7 حالات) ، فرط احتقان الملتحمة &nbsp;(6 حالات) ، ضعف الحس في العين (5 حالات) ، إجهاد العين (3 حالات) ، تحفيز من العينين (3 حالات) ، إفراز من العينين (حالتان) ، حكة في المنطقة التي يتم تطبيق القطرات عليها (حالتان) ، تآكل القرنية (حالة واحدة) ، عيون لزجة (حالة واحدة) ، إدماع (حالة واحدة) ، وذمة (تجمع سوائل) في العين (حالة واحدة).</p><p><strong>لم يتم الإبلاغ عن رد فعل عكسي شديد، ولكن كانت هناك بعض ردود الفعل العكسية غير المتوقعة (2.68%- 24 مريضا / 895</strong> <strong>مريضا، 27 حالة</strong>) الفعالة منها (11 حالة) ، جفاف العين (7 حالات) ، التعب من العين (3 حالات) تحفيز من العين (3 حالات) ، تآكل القرنية (حالة واحدة) ، عيون لاصقة (حالة واحدة ) وذمة من العيون (حالة واحدة).</p><p>-&nbsp;&nbsp;&nbsp; المواد غير الفعالة : يحتوي هذا الدواء على الفوسفات. أما بالنسبة لبعض المرضى الذين لديهم أضرار حادة في القرنية ، وقد تم الإبلاغ أنه يمكن أن يكون هناك تكلس القرنية عند هؤلاء المرضى في حالات نادرة جداً عند استخدام الفوسفات. (0.01٪).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>- &nbsp;يخزن في وعاء محكم على درجة حرارة أقل من ۳۰ درجة مئوية. يجب أن يحفظ هذا الدواء بعيداً عن متناول الأطفال.</p><p>- يجب حفظه بعيداً عن الضوء.</p><p>- لا تستخدم المستحضر بعد تاريخ الانتهاء المدون على الغلاف الخارجي</p><p>- الادوية يجب ان لا يتم التخلص منها عن طريق الصرف الصحي. اسأل الصيدلاني عن طريقة التخلص من الدواء الذي لم تعد تستعمله. وبهذه الطريقة تساهم في حماية البيئة.</p><p>- استخدم المنتج فقط اذا كان ختم الغطاء غير مكسور.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>&nbsp;</strong>تحتوي<strong>&nbsp;</strong>قطرة العين<strong>&nbsp;كلاسجين&nbsp;</strong>على: سايكلوسبورين 0.5 مغ/مل , جليسيرين مركز 0.5 مغ/مل ,فوسفات الصوديوم أحادي الهيدرات أحادي القاعدة ( كمية كافية) فوسفات الصوديوم هيدرات ثنائي القاعدة (كمية كافية) بولي أوكسيل 35 زيت الخروع 30 مغ/مل , إيثانول 1 مغ/مل , ماء للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;</strong>قطرة العين كلاسجين هي محلول شفاف عديم اللون في عبوة بلاستيكية شفافة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;&nbsp;المصنع ومالك حقوق التسويق:</strong></p><p dir="RTL">شركة هيونز</p><p dir="RTL">100، Bio valley-ro، Jecheon-si،</p><p dir="RTL">شنغشيونغباك- دو ، كوريا</p><p dir="RTL">للحصول على أي معلومات حول هذا المنتج الطبي ، يرجى الاتصال بالممثل المحلي لمالك حق التسويق:</p><p dir="RTL"><strong>شركة عمان للصناعات الدوائية</strong></p><p dir="RTL">مدينة الملك عبدالله الثاني الصناعية - سحاب</p><p dir="RTL">عمان 11512 ، الأردن</p><p dir="RTL">&nbsp;</p><p><strong>للتبليغ عن أي آثار جانبية</strong></p><p><u>الأردن</u></p><p>مؤسسة الغذاء و الدواء</p><p>رقم الهاتف: 5632000-06</p><p>الموقع الالكترونيwww.jfda.jo:</p><p>تطبيق الهواتف الذكية&nbsp;&nbsp;&nbsp; &nbsp;Jordan fda :&nbsp;</p><p>نموذج الإبلاغ الورقي&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; yellow card :</p><p>&nbsp;</p><p><u>&nbsp; &nbsp;المملكة العربية السعودية</u></p><p>المركز الوطني للتيقظ والسلامة الدوائية</p><p>الهيئة العامة للغذاء والدواء- مركز الاتصال الموحد: 19999</p><p>البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p>الموقع:https://ade.sfda.gov.sa/</p><p>&nbsp;</p><p><u>&nbsp;الإمارات العربية المتحدة</u></p><p>قسم اليقظة الدوائية والمستلزمات الطبية</p><p>صندوق بريد :1853</p><p>رقم الهاتف: 80011111</p><p>البريد الالكتروني: pv@moh.gov.ae</p><p>قسم الدواء</p><p>وزارة الصحة ووقاية المجتمع</p><p>دبي</p><p>&nbsp;</p><p><u>&nbsp;دول الخليج الأخرى</u></p><p dir="RTL">الرجاء الاتصال بالمؤسسات والهيئات الوطنية في كل دولة</p><table border="0" cellspacing="0" cellpadding="0" align="left"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p><p>&nbsp;</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            د. تمت الموافقة على هذه النشرة في 02/2024


        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                ClasGen Eye Drops
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Active Pharmaceutical Ingredient                                            (mg/mL)
Cyclosporine		USP	0.5 mg
	
Excipients
Concentrated Glycerin		KP	0.5mg
Monobasic Sodium Phosphate Monohydrate		USP	q.s
Dibasic Sodium Phosphate Hydrate		USP	q.s
Polyoxyl 35 Castor oil		NF	30 mg
Ethanol		KP	1 mg
Water for injection		KP	q.s

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Eye drops (Prescription only) 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>- ClasGen Eye Drops is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>&nbsp;</strong></p><p>- Instill one drop of this drug twice a day in each eye approximately 12 hours apart. This drug can be used concomitantly with artificial tears, allowing a 15 minute interval between products.&nbsp; Discard vial after use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                - Patients who have active ophthalmic infection
- Patients who have hypersensitiveness for this drug or might have hypersensitiveness for this drug

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>4.4.1 Warning </strong></p><p><strong>&nbsp;</strong>- As for this drug, there has been no research data for patients who have medical histories related to vesicular keratitis.</p><p>- As for patients who use punctal plug or administer topical anti-inflammatory drug, there has been no increase making tears observed.</p><p>&nbsp;</p><p><strong>4.4.2 General precaution</strong></p><p><strong>&nbsp;</strong>- This drug should be used for ophthalmic disease.</p><p>- Do not touch tip of container to eyes as this may injure the eyes.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&lt;No clinically relevant interactions have been described.&gt;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>-&nbsp;Teratogenic effects: 300mg/kg/day of cyclosporine were administered to rats and rabbits orally, but there was no evidence observed that this drug might occur deformity. As for rats and rabbits, when it is regarded that this dosage is absorbed all, it is around 300,000 times bigger than daily dosage (0.001mg/kg/day) from a person of 60kg who administered the drug one drop on eyes (28㎕).</p><p>- Non-teratogenic effects:</p><p>①&nbsp;As for the reproductive toxicity study from rats and rabbits, the adverse reaction was observed only from the dosage of toxicity in the mothers&rsquo;&nbsp;body. The oral solution of cyclosporine (USP) with toxicity dosage (Rats: 30mg/kg/day, Rabbits: 100mg/kg/day) lead to late development for skeleton as well as weight loss and increase of death from pup. Also, the toxicity was observed for initial development and pup. When it is regarded that all administered dosage is absorbed totally, it is around each 30,000 times and 100,000 times bigger than daily dosage (0.001mg/kg/day) of a person who administered the drug one drop (28㎕) on each eye.</p><p>②&nbsp;The evidence related to toxicity was not observed from rats and rabbits which administered cyclosporine with dosage of each 17mg/kg/day and 30mg/kg/day orally. This dosage is around each 17,000 times and 30,000 times bigger than daily dosage of human.</p><p>③&nbsp;From 15 days after pregnancy to 21 days after partus, the put death rate was increased from the rats which administered 45mg/kg/day (toxicity level from mother&rsquo;s body of cyclosporine). When it is regarded that all administered dosage is absorbed totally, it is 45,000 times bigger than daily dosage (0.001mg/kg/day) of human.</p><p>④&nbsp;No clinical study data for pregnant woman yet. Therefore, this drug should be administered carefully when it is needed definitely.</p><p>⑤&nbsp;Cyclosporine is known that it is affected to the breast feeding if it is systemic administration, but for topical administration, it was not researched. Although the blood concentration is not observed, it should be careful if it is administered to pregnant woman.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>&nbsp;</strong>- Commonest adverse reaction: Ocular burning (17%)</p><p>- Other adverse reaction reported from 1 ~ 5 % patients: conjunctival hyperemia, discharge, epiphora, eye pain, foreign body sensation, pruritus, stinging and visual disturbance (Most often blurring)</p><p>- Adverse reaction from post marketing: Difficult to estimate the frequency or establish a causal relationship to drug exposure, but reported that there have been eye swelling, hypersensitivity (including rare cased of sever angioedema, face swelling, tongue swelling, pharyngeal edema, and dyspnea), superficial injury of the eye (from the vial tip touching the eye during administration), burning sensation, pruritus, and hives.</p><p>- Post marketing Surveillance in domestic market</p><p>In South Korea market, the adverse reaction has been studied with 895 patients who have ophthalmic infection for 6 years after launching the product, and the symptom incident was 7.82% without a casual relation (70 patients/895 patients, 93 cases). Among those cases, the adverse reaction, which should be considered of its casual relation, was 6.48% (58 patients/ 895 patients, 76 cases) and it was reported that there were burning sensation from applied parts (26 cases), not effectiveness (11 cases), eye dry (7 cases), ophtalmalgia (7 cases), hyperaemia conjunctivae (6 cases), dysaesthesia from eyes (5 cases), tiredness from eyes (3 cases), stimulation from eyes (3 cases), secretion from eyes (2 cases), pruritus from applied parts (2 cases), corneal erosion (1 case), sticky eyes (1 case), epiphora (1 case), edema from eyes (1 case).</p><p>Severe adverse reaction was not reported, but there were some unexpected adverse reactions (2.68% - 24 patients/895patients, 27 cases) which are effectiveness (11 cases), dry eye (7 cases), tiredness from eyes (3 cases) stimulation from eyes (3 cases), corneal erosion (1 case), sticky eyes (1 case) and edema from eyes (1 case).</p><p>- Excipients: This drug contains phosphate. As for some patients who have severe corneal damage, it was reported that there could be cornea calcification for these patients very rarely when used phosphate. (0.01%).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>- Product Name: ClasGen Eye Drops</p><p>- CAS#: 59865-13-3</p><p>- Chemical Name: Cyclosporine</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption</strong></p><p>The absorption of cyclosporine after topical ocular administration of a castor oil emulsion formulation has been studied in two nonclinical species; rabbit and dog.&nbsp; Both species had significant absorption of cyclosporine in nictitating membrane, conjunctiva and cornea with substantially less detected in other ocular tissues.&nbsp; Some accumulation was observed in cornea, lens and iris-ciliary body but limited in conjunctiva and sclera after multiple dosing. Systemic absorption after topical ocular administration in these two species was minimal with maximal plasma concentrations of less than 1 ng/mL.&nbsp; In humans, ophthalmic cyclosporine castor oil emulsions results in very low systemic levels of cyclosporine as well.</p><p>Bioavailability of cyclosporine varies considerably after administration with standard oral formulations with a mean value of 30% and range of 1 to 89%.&nbsp; Food intake may have substantial effect on the rate and extent of absorption with standard oral formulations.</p><p>&nbsp;</p><p><strong>Distribution</strong></p><p>Cyclosporine after topical ocular administration distributed poorly into intraocular tissues, e.g. cornea and conjunctiva from extraocular tissues, e.g. iris-ciliary body and aqueous humor in both rabbit and dog.&nbsp; Limited contralateral distribution from the treated to the untreated eye was observed in rabbit most notably detected in lens, choroid-retina, vitreous humor, lacrimal gland and optic nerve.</p><p>Cyclosporine is widely distributed systemically after intravenous administration with a volume of distribution ranging from 0.9 to 4.8 L/kg.&nbsp; Cyclosporine is bound to erythrocytes with a blood: plasma ratio of 2. Plasma protein binding is approximately 80% with most binding to lipoproteins.</p><p>&nbsp;</p><p><strong>Biotransformation</strong></p><p>Biotransformation of cyclosporine in ocular tissues after topical ocular administration was not detected. After oral dosing, cyclosporine is extensively metabolized which includes hydroxylation and demethylation of the parent drug in the liver primarily by CYP3A4.&nbsp; The interpatient variability of cyclosporine disposition after oral administration is large, and drug-drug interactions (DDIs) with CYP3A4 inhibitors and inducers significantly contribute to this variability.&nbsp; In addition, cyclosporine and some of its metabolites are known P-glycoprotein substrates and/or inhibitors; however, P-glycoprotein expression and cyclosporine disposition studies have generated inconclusive results.</p><p>&nbsp;</p><p><strong>Elimination</strong></p><p>Calculated half-life of cyclosporine after topical ocular administration of castor oil emulsion (0.2%) varied among the tissues and species (rabbit or dog) and ranged from 14.6 hours (lacrimal gland of the dog) to 44 hours (iris-ciliary body of the rabbit).</p><p>Systemically, cyclosporine and its metabolites are eliminated through biliary excretion with renal excretion as a minor pathway.&nbsp; Less than 1% of the dose is eliminated unchanged in the urine while only 6% of the dose was eliminated in the urine as parent drug and metabolites.&nbsp; The elimination half-life of cyclosporine in healthy volunteers after systemic dosing averaged 6.3 hours.</p><p>&nbsp;</p><p><strong>Linearity/non-linearity</strong></p><p>With increasing doses of cyclosporine in topical ocular castor oil emulsions from 0.05% to 0.4%, dose proportionality was found in some ocular tissues but not in others.</p><p>&nbsp;</p><p><strong>Pharmacokinetic/pharmacodynamic relationship(s)</strong></p><p>No pharmacokinetic/pharmacodynamics relationship has been described for cyclosporine after topical ocular administration.</p><p>&nbsp;</p><p><strong>Pharmacokinetics of special populations</strong></p><p>Renal failure and hemodialysis do not affect the pharmacokinetics of cyclosporine.&nbsp; Severe liver disease decreases the absorption of cyclosporine as well as increasing serum half-life after systemic dosing.&nbsp; Pharmacokinetics of cyclosporine after oral dosing is influenced by age.&nbsp; Pediatric patients appear to clear the drug more rapidly than adults.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>- Non-clinical data reveal no special hazards, at the indicated route and dose, for humans based on conventional studies evaluating repeated dose toxicity, genotoxicity, carcinogenic potential and toxicity to reproduction and development.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This drug contains following excipients: Concentrated Glycerin (used as an isotonic agent), Monobasic Sodium Phosphate Monohydrate (used as a pH adjuster), Dibasic Sodium Phosphate Hydrate (used as a pH adjuster), Polyoxyl 35 castor oil (used as a solvent), Ethanol (used as a solvent) and Water for injection (used as a solvent).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months from the date of manufacture
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store in an airtight container below 30&deg;C</p><p>Should be protected from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;0.4 mL x 30 EA</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>- To avoid contamination, never touch the tip of the vial to any surface.</p><p>- Use before the expiration date marked on the product.</p><p>- Do not use if the product changes color.</p><p>- TAMPER EVIDENT: Do not use if security seal is damaged or missing. Do not use if package has been opened or damaged.</p><p>- If swallowed, get medical help.</p><p>- Keep out of the reach of children.</p><p>- Store at room temperature.</p><p>- One individual single-use vial is to be used immediately after opening.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Amman Pharmaceutical Industries
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Oct, 2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>